Interestingly, while there is global loss of H3K27me3-repressive marks in EZHIP-overexpressing tumors, this is accompanied by increased levels of H3K27me3 at the CDKN2A locus in PFA ependymomas expressing EZHIP. The gene discussed is EZHIP; the disease is ependymoma.